Zofia Kachlik, M.D. currently a resident physician at the Department of Adult Psychiatry of the University Clinical Centre, the Medical University of Gdańsk's teaching hospital, and Michał Walaszek, M.D. presented their research findings at the European College of Neuropsychopharmacology (ECNP) Congress in Munich. Both are involved in research activities at the Department of Adult Psychiatry. At one of Europe's leading scientific events dedicated to neuropsychopharmacology, they presented two research posters examining the use of ketamine in the treatment of treatment-resistant depression. Bot